Phase II clinical study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic breast cancer

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2009
This article has no abstract
Epistemonikos ID: 40bc54dbd5186a5e925be1f9582c66bcc12a998c
First added on: Apr 17, 2025